Periodic Reporting for period 2 - FuturoLEAF (Leaf-inspired nanocellulose frameworks for next generation photosynthetic cell factories)
Período documentado: 2021-09-01 hasta 2023-12-31
Targeting sustainable production of a wide spectrum of chemicals, FuturoLEAF used three industrially relevant model processes to demonstrate production of high-value products such as pharmaceutically active ingredients (APIs) and natural cosmetics, specialty chemicals such as ε-caprolactone and commodity chemicals such as hydrogen and ethylene. To this end, the project optimized multiple photosynthetic and heterotophic strains for the efficient production of volatile and soluble compounds, as well as constructed several high-performance solid-state matrix architectures tailored for different production conditions. Finally, an upscaled proof-of-concept SSPCF architecture was established for long-term ethylene production, meeting or exceeding all project key performance indicators.
FuturoLEAF contributes significantly to society by developing the biotechnology field with direct impact to existing biotechnological companies utilizing photosynthetic cells. Additionally, it is envisioned that FuturoLEAF can enable the birth of new biotechnological companies, where solid-state cell factories will be utilized with one or multiple cell types, creating new business openings in the EU. The novel technology created within FuturoLEAF will also give EU a marketing advantage over other market areas related to bioproduction. Moreover, FuturoLEAF will contribute to environmental safety and the development of green technologies. Implementation of the knowledge created in FuturoLEAF for green technology will lead to sustainable use of resources by conversion of CO2 and light into chemicals.
Natural and recombinant photoautotrophic and heterotrophic production strains were selected and optimized to efficiently produce chemicals in relevant reference systems, i.e. in suspension and immobilized in alginate. The production systems encompass a “substrate-in” approach for APIs, “substrate-in-product-out” approach for production of ε-caprolactone via whole-cell biotransformation, and “product-out” approaches for both soluble natural cosmetics and sucrose, and volatile hydrogen and ethylene. Heterotrophic microorganisms were also engineered for potential co-culturing approaches.
Tailored matrix layers were fabricated from the matrix building blocks with optimized wet strength, light distribution, and porosity for the different production systems. Wet-stable nanocellulosic hydrogels were identified as the most suitable matrices for volatile chemical production, whereas porous and wet-stable nanocellulose and nanochitin cryogels were developed for nonvolatile systems requiring higher mass transfer. Finally, the biocatalytical solid-state photosynthetic cell factory architecture was up-scaled in a photobiofilm-reactor for prolonged chemical production. In the final TRL 3 proof-of-concept, continuous production of volatile chemicals was demonstrated with nearly 300-fold increase in volumetric productivity compared to suspended cells.
The outcomes of the project were published in 14 peer reviewed articles, with additional 20 manuscripts under preparation. The results were disseminated in 54 conference talks and 21 poster presentations. The project also resulted in 1 PhD thesis, with 6 PhD works under way, 4 Master’s theses, and 1 Bachelor’s thesis. Additionally, FuturoLEAF teamed up with scientific journalist and professional screenwriter Nina Pulkkis form Photino Science Communication to produce promotional video material for the project. Market analysis suggested that production of high-value compounds with reproducible conditions and low batch variation is the primary market for the SSPCF production platform. Moreover, few relevant patents were found in the IPR analysis, ensuring freedom-to-operate for the continued development of the FuturoLEAF technologies.